Sponsor content
180 result(s) found, displaying 31 to 40
-
Australian public assessment report (AusPar)AusPAR for Camzyos (mavacamten) for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ONUREG azacitidine 200 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ONUREG azacitidine 300 mg film-coated tablet blister pack.
-
Australian public assessment report (AusPar)AusPAR for Opdivo (nivolumab) for the treatment of adjuvant treatment of patients with muscle invasive urothelial carcinoma (MIUC).
-
Prescription medicine registrationActive ingredients: Ipilimumab.
-
Prescription medicine registrationActive ingredients: nivolumab.
-
Prescription medicine registrationActive ingredients: nivolumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for REBLOZYL luspatercept 25 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for REBLOZYL luspatercept 75 mg powder for injection vial.
-
Prescription medicine decision summarySotyktu (deucravacitinib) is approved to treat plaque psoriasis.